Avanos Medical, Inc. (AVNS) stock rallied over 0.59% intraday to trade at $27.34 a share on NYSE. The stock opened with a gain of 2.67% at $26.67 and touched an intraday high of $27.46, rising 0.59% against the last close of $27.18. The stock went to a low of $26.7 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue744.6 Million
5Y Sales Change5.60%
Fiscal Year Ends2021-12-30
IndustryHealth Care Supplies
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Avanos Medical, Inc. (NYSE: AVNS) stock price is $27.34 as of the last check on Thursday, June 30. During the trading session, AVNS stock reached the peak price of $27.46 while $26.7 was the lowest point it dropped to.
The NYSE listed AVNS is part of Health Care Supplies industry that operates in the broader Health Care sector. Avanos Medical, Inc. , a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
Mr. Joseph F. Woody
CEO & Director
Mr. Michael C. Greiner
Sr. VP, CFO & Principal Accounting Officer
Mr. David Edward Ball
Sr. VP of Global Supply Chain & Procurement
Mr. William David Haydon
Sr. VP & GM of Pain Management
AVNS stock traded closed the last session at $27.34, which is $0.16 or 0.59% lower than its previous close of $27.18. AVNS's current trading price is 11.41% lower than its 52-week high of $38.82 where as its distance from 52-week low of 24.54% is -29.57%.
Number of AVNS employees currently stands at -. AVNS operates from 5405 Windward Parkway, Suite 100 South, Alpharetta, GA 30004, United States.
Official Webiste of $AVNS is: https://avanos.com
AVNS stock volume for the day was 332,325 shares while in the previous session number of AVNS shares traded was 332,870 . The average number of AVNS shares traded daily for last 3 months was 279.36 Thousands.
The percentage change in AVNS stock occurred in the recent session was 0.59% while the dollar amount for the price change in AVNS stock was $0.16.
In the recent session, the day high for AVNS stock was $27.46 while the low for AVNS stock touched on the day was $26.7.
The market value of AVNS currently stands at 1.26 Billion with its latest stock price at $27.34 and 47.4 Million of its shares outstanding.